Why Lemelson Capital Is Short On Ligand Pharmaceuticals By: Benzinga via Benzinga October 17, 2014 at 15:52 PM EDT Rev. Emmanuel Lemelson is the Chief Investment Officer of Lemelson Capital Management, and investment firm that is short in Ligand ... Read More >> Related Stocks: Berkshire Hathaway Ligand Pharm